Detalles de la búsqueda
1.
A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes.
Kidney Int
; 105(3): 618-628, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38101515
2.
Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study.
Am J Kidney Dis
; 83(3): 293-305.e1, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37839687
3.
Successful implementation of a stakeholder engagement program for pharmacoepidemiologic research.
Pharmacoepidemiol Drug Saf
; 33(1): e5727, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37985010
4.
Improving the accuracy of automated gout flare ascertainment using natural language processing of electronic health records and linked Medicare claims data.
Pharmacoepidemiol Drug Saf
; 33(1): e5684, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37654015
5.
Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial Fibrillation.
JAMA Netw Open
; 6(3): e234086, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36976562
6.
A Novel Chronic Kidney Disease Phenotyping Algorithm Using Combined Electronic Health Record and Claims Data.
Clin Epidemiol
; 15: 299-307, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36919110
Resultados
1 -
6
de 6
1
Próxima >
>>